[go: up one dir, main page]

AT375399B - Verfahren zur herstellung des neuen therapeutisch wirksamen cyclosporin g - Google Patents

Verfahren zur herstellung des neuen therapeutisch wirksamen cyclosporin g

Info

Publication number
AT375399B
AT375399B AT0672679A AT672679A AT375399B AT 375399 B AT375399 B AT 375399B AT 0672679 A AT0672679 A AT 0672679A AT 672679 A AT672679 A AT 672679A AT 375399 B AT375399 B AT 375399B
Authority
AT
Austria
Prior art keywords
producing
therapeutically active
new therapeutically
active cyclosporin
cyclosporin
Prior art date
Application number
AT0672679A
Other languages
English (en)
Other versions
ATA672679A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to AT14782A priority Critical patent/AT381102B/de
Priority to AT14682A priority patent/AT381101B/de
Publication of ATA672679A publication Critical patent/ATA672679A/de
Application granted granted Critical
Publication of AT375399B publication Critical patent/AT375399B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/885Trichoderma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT0672679A 1978-10-18 1979-10-16 Verfahren zur herstellung des neuen therapeutisch wirksamen cyclosporin g AT375399B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT14782A AT381102B (de) 1979-08-15 1982-01-18 Verfahren zur herstellung von neuem isocyclosporin g
AT14682A AT381101B (de) 1979-03-22 1982-01-18 Verfahren zur herstellung von neuem dihydrocyclosporin g

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1077678A CH637124A5 (en) 1978-10-18 1978-10-18 Antibiotic, its preparation and use

Publications (2)

Publication Number Publication Date
ATA672679A ATA672679A (de) 1983-12-15
AT375399B true AT375399B (de) 1984-07-25

Family

ID=4366764

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0672679A AT375399B (de) 1978-10-18 1979-10-16 Verfahren zur herstellung des neuen therapeutisch wirksamen cyclosporin g

Country Status (5)

Country Link
JP (1) JPS5555150A (de)
AT (1) AT375399B (de)
BE (1) BE879402A (de)
CH (1) CH637124A5 (de)
ZA (1) ZA795560B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
DE69222150T2 (de) * 1991-01-25 1998-01-15 Fujisawa Pharmaceutical Co Prozess zur produktion von cyclosporin-a und/oder c

Also Published As

Publication number Publication date
ZA795560B (en) 1981-05-27
CH637124A5 (en) 1983-07-15
JPS5555150A (en) 1980-04-22
JPS6340200B2 (de) 1988-08-10
BE879402A (fr) 1980-04-15
ATA672679A (de) 1983-12-15

Similar Documents

Publication Publication Date Title
AT369750B (de) Verfahren zur herstellung des neuen 11-aza-4-0cladinosyl-6-0-desosaminyl-15-aethyl-7,13,14-
AT347582B (de) Verfahren zur herstellung des neuen 4'- deoxydaunomycins
AT374194B (de) Verfahren zur herstellung des neuen 2-(2-thenoylthio)-propionylglycin
AT367011B (de) Verfahren zur herstellung des neuen 1(s), 4(r),
AT366065B (de) Verfahren zur herstellung des neuen 17alpha-
AT362499B (de) Verfahren zur herstellung des neuen anti- biotisch wirksamen deosynarasinkomplexes
AT351689B (de) Verfahren zur herstellung des neuen l- pyroglutamyl-l-prolinamids
AT366365B (de) Verfahren zur herstellung von neuen 4-nitro-2trichlormethylphenyldisulfiden
AT362872B (de) Verfahren zur herstellung von neuen demethylmaytansinoiden
ATA271877A (de) Verfahren zur herstellung des neuen n-n-butyl-n-cetyl-6-amino-1-hexanols
AT375399B (de) Verfahren zur herstellung des neuen therapeutisch wirksamen cyclosporin g
AT366363B (de) Verfahren zur herstellung des neuen alpha-n-acetyl-l-phenylalanyl-l-arginin-aethyles ers
AT367771B (de) Verfahren zur herstellung des neuen chlormethyl -17alpha-acetoxy-9alpha-fluor-11beta-hydroxy -16beta-methyl-3-oxoandrosta-1,4-dien-17beta -carboxylats
AT364347B (de) Verfahren zur herstellung von neuen 1beta-hydroxy-2beta-alkenyl-3-methylencyclopentan-4 beta-yl-cyclopropancarboxylaten
AT361010B (de) Verfahren zur herstellung des neuen 1,6-di-0- methansulfonyl-3,4-di-0-methyl-d-mannits
AT351014B (de) Verfahren zur herstellung des neuen 2-methyl- 4-trifluormethylanilins
AT362067B (de) Verfahren zur herstellung von neuen deoxyanthracyclinen
AT365642B (de) Verfahren zur herstellung des neuen cyclosporin d
AT373238B (de) Verfahren zur herstellung des neuen 4-amino-5-
AT360977B (de) Verfahren zur herstellung des neuen m-fluor- benzimidoylacetonitrils
AT357562B (de) Verfahren zur herstellung des neuen n-methoxy- carbonyl-n'-trifluormethansulfonylhydrazins
AT362772B (de) Verfahren zur herstellung des neuen (+)-alphacyan-m-phenoxybenzyl-(+)-alpha-isopropyl-4-dioder -trifluormethoxyphenylacetats
ATA553981A (de) Verfahren zur herstellung des neuen 17beta-n,n-
ATA554081A (de) Verfahren zur herstellung des neuen 17beta-n,n-
ATA350681A (de) Verfahren zur herstellung des neuen chlormethyl-17alpha-acetoxy-9alpha-fluor-11beta hydroxy-16betamethyl-3-oxo-androsta-1,4-dien-17beta-carboxyla s

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee